Streetbeat News

Earnings

QTRX

Quanterix reported Q4 earnings with a loss of $(0.33) per share, missing the $(0.32) estimate, but sales of $31.55M exceeded the $29.84M estimate, marking a 22.17% increase from last year.

Portfolio Pulse from Happy Mohamed

February 29, 2024 | 9:15 pm

SG

Sweetgreen (NYSE:SG) reported Q4 earnings with an EPS of $-0.24, missing estimates by -14%, and revenue up $34.46 million YOY. The company previously missed EPS estimates last quarter, leading to a 12% share price drop the following day.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 9:15 pm

ORGO

Organogenesis Holdings (NASDAQ:ORGO) reported Q4 earnings with an EPS of $0.01, matching estimates but with a revenue decrease of $15.87 million from the previous year. Despite matching EPS estimates this quarter, the company had previously beaten EPS estimates in Q3 2023, which led to an 11.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 9:15 pm

TTEC

TTEC Holdings (NASDAQ:TTEC) reported Q4 earnings with a miss on estimated earnings by -5.0%, posting an EPS of $0.37 against an estimate of $0.39. Revenue decreased by $32.10 million from the same period last year. In the previous quarter, the company exceeded EPS estimates which was followed by a 29% drop in share price the next day.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 9:15 pm

TTEC

TTEC Holdings reported Q4 2023 adjusted EPS of $0.370, missing the $0.390 estimate, but sales of $626.181M exceeded the $603.479M estimate. This represents a 4.88% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:14 pm

ATRI

Atrion Corporation reported a decrease in Q4 earnings per share by 22.34% year-over-year, from $4.70 to $3.65. However, their sales saw a slight increase of 1.70% from $42.85 million to $43.58 million in the same period.

Portfolio Pulse from Happy Mohamed

February 29, 2024 | 9:14 pm

ESTC

Elastic shares are trading lower following the announcement of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:14 pm

GRTS

Gritstone bio announced a 40% reduction in its workforce due to a lack of near-term funding, following a delay in the CORAL Phase 2b study which led to the loss of anticipated external funding starting in 1Q 2024.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:14 pm

NTAP

NetApp's shares surged following the announcement of their Q3 financial results, which exceeded expectations. The company also provided positive guidance for the future.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:14 pm

VYX

NCR Voyix announced a delay in its 10-K filing due to the discovery of fraudulent ACH disbursements from a company bank account and additional processes required after a spin-off. The company is in the process of completing its financial statements and other disclosures and will file for an extension.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 9:14 pm